LEVOMEPROMAZINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for levomepromazine and what is the scope of freedom to operate?
Levomepromazine
is the generic ingredient in one branded drug marketed by Immunex and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for levomepromazine.
Summary for LEVOMEPROMAZINE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Clinical Trials: | 3 |
| Patent Applications: | 6,029 |
| DailyMed Link: | LEVOMEPROMAZINE at DailyMed |
Recent Clinical Trials for LEVOMEPROMAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hannover Medical School | Phase 3 |
| Instituto de Salud Carlos III | Phase 3 |
| Fundación Pública Andaluza Progreso y Salud | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for LEVOMEPROMAZINE
US Patents and Regulatory Information for LEVOMEPROMAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | LEVOPROME | levomepromazine | INJECTABLE;INJECTION | 015865-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
